Advocate

Country: European Union

Language: Romanian

Source: EMA (European Medicines Agency)

Buy It Now

Active ingredient:

imidacloprid, moxidectin

Available from:

Bayer Animal Health GmbH

ATC code:

QP54AB52

INN (International Name):

imidacloprid, moxidectin

Therapeutic group:

Dogs; Cats; Ferrets

Therapeutic area:

Produse antiparazitare, insecticide și repellente

Therapeutic indications:

DogsFor câini infestați sau expuși riscului de infecții parazitare mixte:tratamentul și prevenirea infestării cu purici (Ctenocephalides felis),tratamentul cu păduchi malofagi (Trichodectes canis),tratarea râiei auriculare (Otodectes cynotis), râiei sarcoptice (determinata de Sarcoptes scabiei var. canis), demodecia (cauzate de Demodex canis),prevenirea dirofilariozei cardiace (larve L3 și L4 de Dirofilaria immitis),tratamentul de microfilarii circulante (Dirofilaria immitis),tratamentul dirofilariozei cutanate (adult etape de Dirofilaria repens)prevenirea dirofilariozei cutanate (larve L3 de Dirofilaria repens),reducerea de microfilarii circulante (Dirofilaria repens),prevenirea angiostrongylosis (larve L4 și adulți imaturi de Angiostrongylus vasorum),tratamentul infestării cu Angiostrongylus vasorum și Crenosoma vulpis,prevenirea spirocercosis (Spirocerca lupi),tratamentul Eucoleus (syn. Capillaria) boehmi (adulți),tratamentul ochiului worm Thelazia callipaeda (adulți),tratamentul infectiilor cu nematode gastrointestinale (larve L4, adulți imaturi și adulți de Toxocara canis, Ancylostoma caninum și Uncinaria stenocephala, adulți de Toxascaris leonina și Trichuris vulpis). Produsul poate fi utilizat ca parte a unei strategii de tratament pentru dermatita alergică la purici (FAD). CatsFor pisici infestate sau expuse riscului de infecții parazitare mixte:tratamentul și prevenirea infestării cu purici (Ctenocephalides felis),tratarea râiei auriculare (Otodectes cynotis),tratamentul notoedric mange (Notoedres cati),tratamentul pulmonari Eucoleus aerophilus (syn. Capillaria aerophila) (adulți),prevenirea pulmonari boala (L3/L4 larve de Aelurostrongylus abstrusus),tratamentul pulmonari Aelurostrongylus abstrusus (adulți),tratamentul ochiului worm Thelazia callipaeda (adulți),prevenirea dirofilariozei cardiace (larve L3 și L4 de Dirofilaria immitis),tratamentul infectiilor cu nematode gastrointestinale (larve L4, adulți imaturi și adulți de Toxocara cati și Ancylostoma tubaeforme). Produsul poate fi utilizat ca parte a unei strategii de tratament pentru dermatita alergică la purici (FAD). FerretsFor dihori infestați sau expuși riscului de infecții parazitare mixte:tratamentul și prevenirea infestării cu purici (Ctenocephalides felis),prevenirea dirofilariozei cardiace (larve L3 și L4 de Dirofilaria immitis).

Product summary:

Revision: 23

Authorization status:

Autorizat

Authorization date:

2003-04-02

Patient Information leaflet

                                OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
+31 (0)88 781
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Informații actualizate cu privire la acest medicament de uz veterinar
sunt disponibile pe site-ul cu
informații privind medicamentele de uz veterinar.
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
+31 (0)88 781
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Informații actualizate cu privire la acest medicament de uz veterinar
sunt disponibile pe site-ul cu
informații privind medicamentele de uz veterinar.
                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet Bulgarian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Bulgarian 31-01-2024
Public Assessment Report Public Assessment Report Bulgarian 29-01-2024
Patient Information leaflet Patient Information leaflet Spanish 31-01-2024
Public Assessment Report Public Assessment Report Spanish 29-01-2024
Patient Information leaflet Patient Information leaflet Czech 31-01-2024
Public Assessment Report Public Assessment Report Czech 29-01-2024
Patient Information leaflet Patient Information leaflet Danish 31-01-2024
Public Assessment Report Public Assessment Report Danish 29-01-2024
Patient Information leaflet Patient Information leaflet German 31-01-2024
Public Assessment Report Public Assessment Report German 29-01-2024
Patient Information leaflet Patient Information leaflet Estonian 31-01-2024
Public Assessment Report Public Assessment Report Estonian 29-01-2024
Patient Information leaflet Patient Information leaflet Greek 31-01-2024
Public Assessment Report Public Assessment Report Greek 29-01-2024
Patient Information leaflet Patient Information leaflet English 31-01-2024
Public Assessment Report Public Assessment Report English 29-01-2024
Patient Information leaflet Patient Information leaflet French 31-01-2024
Public Assessment Report Public Assessment Report French 29-01-2024
Patient Information leaflet Patient Information leaflet Italian 31-01-2024
Public Assessment Report Public Assessment Report Italian 29-01-2024
Patient Information leaflet Patient Information leaflet Latvian 31-01-2024
Public Assessment Report Public Assessment Report Latvian 29-01-2024
Patient Information leaflet Patient Information leaflet Lithuanian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Lithuanian 31-01-2024
Public Assessment Report Public Assessment Report Lithuanian 29-01-2024
Patient Information leaflet Patient Information leaflet Hungarian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Hungarian 31-01-2024
Public Assessment Report Public Assessment Report Hungarian 29-01-2024
Patient Information leaflet Patient Information leaflet Maltese 31-01-2024
Public Assessment Report Public Assessment Report Maltese 29-01-2024
Patient Information leaflet Patient Information leaflet Dutch 31-01-2024
Public Assessment Report Public Assessment Report Dutch 29-01-2024
Patient Information leaflet Patient Information leaflet Polish 31-01-2024
Public Assessment Report Public Assessment Report Polish 29-01-2024
Patient Information leaflet Patient Information leaflet Portuguese 31-01-2024
Summary of Product characteristics Summary of Product characteristics Portuguese 31-01-2024
Public Assessment Report Public Assessment Report Portuguese 29-01-2024
Patient Information leaflet Patient Information leaflet Slovak 31-01-2024
Public Assessment Report Public Assessment Report Slovak 29-01-2024
Patient Information leaflet Patient Information leaflet Slovenian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Slovenian 31-01-2024
Public Assessment Report Public Assessment Report Slovenian 29-01-2024
Patient Information leaflet Patient Information leaflet Finnish 31-01-2024
Public Assessment Report Public Assessment Report Finnish 29-01-2024
Patient Information leaflet Patient Information leaflet Swedish 31-01-2024
Public Assessment Report Public Assessment Report Swedish 29-01-2024
Patient Information leaflet Patient Information leaflet Norwegian 31-01-2024
Summary of Product characteristics Summary of Product characteristics Norwegian 31-01-2024
Public Assessment Report Public Assessment Report Norwegian 29-01-2024
Patient Information leaflet Patient Information leaflet Icelandic 31-01-2024
Summary of Product characteristics Summary of Product characteristics Icelandic 31-01-2024
Public Assessment Report Public Assessment Report Icelandic 29-01-2024
Patient Information leaflet Patient Information leaflet Croatian 31-01-2024
Public Assessment Report Public Assessment Report Croatian 29-01-2024

Search alerts related to this product

View documents history